Windham Life Sciences Partners IV, L.P.

Amendment
CIK: 0001999637·Pooled Investment Fund·DELAWARE·Filed: Nov 8, 2023
Total Offering

$200,000,000

Amount Sold

$1,250,000

Investors

3

First Sale

Oct 27, 2023

Offering Details

Type
Equity, Pooled Investment Fund
Exemptions
Rule 506(b), Section 3(c), Section 3(c)(1)
Entity Type
Limited Partnership
Year Incorporated
2023
Non-Accredited Investors
No

Related Persons

NameRole
Adam E Fine
Related Person
Adam E Windham Life Sciences Partners General Partner IV, LLC
Related Person

Company

Windham Life Sciences Partners IV, L.P.

500 FIFTH AVENUE

NEW YORK, NY, 10110

(917) 848-3935

SEC Filing

0001999637-23-000002

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Windham Life Sciences Partners IV, L.P. Form D Filing — $200,000,000 | FilingFlow